Author

S. Kalyanaraman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:protein structure· 1 Assay:proteomics· 1 Research Focus:variant calling· 1 Organism:yeast· 1

Frequent Co-Authors

A. Naqvi· 2 shared A. Srivastava· 2 shared B. Kumar· 2 shared D. Kumar· 2 shared D. Parashar· 2 shared I. Singh· 2 shared J. Paliwal· 2 shared K. Arora· 2 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Naqvi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivOct 30, 2020

PRAK-03202: A triple antigen VLP vaccine candidate against SARS CoV-2

S. Mazumder, R. Rastogi, A. Undale…·P. K. Kundu

This paper develops a triple antigen VLP vaccine candidate, PRAK-03202, against SARS-CoV-2 and shows it induces neutralizing antibodies and Th1 immune responses in mice.

DOI 10.1016/j.heliyon.2021.e08124

mouseproteomics

𝕏 PostBluesky

BiochemistrybioRxivPreprintMay 18, 2020

Multi-Antigenic Virus-like Particle of SARS CoV-2 produced in Saccharomyces cerevisiae as a vaccine candidate

K. Arora, R. Rastogi, N. M. Arora…·P. K. Kundu

The paper reports the production of a multi-antigenic SARS CoV-2 virus-like particle (VLP) in Saccharomyces cerevisiae as a vaccine candidate, confirmed by TEM and analytical data.

DOI 10.1101/2020.05.18.099234

yeastprotein structure

𝕏 PostBluesky